CLINICAL_TRIALS
trial_result
· 2017-12-02
Clinical Trial Update: Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women [Phase 3]
Summary
Phase 3 trial evaluating protease inhibitors to reduce malaria morbidity in HIV-infected pregnant women has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of California, San Francisco | Conditions: Malaria, HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2017-12-02